Ledger.Open graph →
SEC Form D · filed March 21, 2025

Biolinq Inc

Offering
$100.0M
Sold
$90.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Derek Rapp · SAN DIEGO, CADirectorDavid A. Berry · SAN DIEGO, CADirectorDan Bradbury · SAN DIEGO, CADirectorChris Dimitropoulos · SAN DIEGO, CADirectorDavid A. Arida · SAN DIEGO, CAExecRichard Yang · SAN DIEGO, CAExec · DirectorThad Johnson · SAN DIEGO, CADirectorZina A. Besse · SAN DIEGO, CADirectorJared A. Tangney · SAN DIEGO, CAExecDerek Rapp · SAN DIEGO, CADirectorDavid A. Arida · SAN DIEGO, CAExecThad Johnson · SAN DIEGO, CADirectorJared A. Tangney · SAN DIEGO, CAExecDavid A. Berry · SAN DIEGO, CADirectorChris Dimitropoulos · SAN DIEGO, CADirectorDan Bradbury · SAN DIEGO, CADirectorRichard Yang · SAN DIEGO, CAExec · DirectorZina A. Besse · SAN DIEGO, CADirectorSunil Chhaya · Palo Alto, CAExecPhilip Cockriel · Arlington, TXDirectorMark J. Pate · KNOXVILLE, TNExecGeorge Bashforth · Grand Cayman, Cayman IslandsDirectorJeffrey M. Smith · San Francisco, CADirectorStepchange Fund I GP, LLC · Seattle, WAExec · DirectorArmaan Ali · San Francisco, CADirectorMort Bloomberg · Jerusalem, L3DirectorJorn Vicari · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗